American Medical Autism Board Launched
First of its kind board / diplomate certification program for autism spectrum disorders
Cleveland, OH - Dr. Phillip C. DeMio, Chairman of the American Medical Autism Board, announced the commencement of the newly founded American Medical Autism Board (www.asdboards.org) at the US Autism & Asperger Association annual conference this past week in Austin, Texas. “This is the first of its kind board / diplomate certification program for medical doctors specializing in biomedical treatment of autism and related disorders,” explained Dr. DeMio.
“Medical doctors who become certified by the American Medical Autism Board (AMAB) show that they specialize in biomedical treatment of autism spectrum disorders, and will have met the Board’s high levels of criteria for training and experience, and will have passed its rigorous certification examination,” said Dr. DeMio. “The biomedical concept means that autism and the autism spectrum disorders are not primary psychiatric or behavioral disorders, rather they are medical diseases with a biologic basis to their cause and to their ongoing manifestations (such as pain, gastrointestinal problems, and immune dysfunction).”
AMAB board-certified members provide biomedical evaluation and/or treatment to individuals of all ages diagnosed with autism spectrum disorders, Asperger's syndrome, AD/HD, OCD, and PDD’s. Through its credentialing process, AMAB offers both the public and private sectors an avenue for identifying well-qualified professionals trained and experienced in the biomedical assessment and treatment of autism spectrum disorders.
Thousands of families that have an affected child will now have access to certified specialists in biomedical autism treatments
Thousands of families that have an affected child will now have access to certified specialists in biomedical autism treatments; verification that AMAB physicians are up to date on the newest treatments and research;
dedication to high quality patient care; and, verification of exceptional knowledge, experience, and skills in their specialty.
About American Medical Autism Board
The American Medical Autism Board® (AMAB) is an independent non-profit incorporated certifying organization. The mission of the American Medical Autism Board is to promote safe, ethical, efficacious medical autism treatment to the public by maintaining high standards for the examination and certification of physicians as autism medical specialists. The mission of AMAB is to contribute to understanding the etiology diagnosis, and treatment of autism spectrum disorders, with the goal of improving the lives of affected individuals and their loved ones.
An epidemiological analysis of the ‘autism as mercury poisoning’ hypothesis
Life and Social Sciences, Swinburne University of Technology, Melbourne, Australia
International Journal of Risk & Safety in Medicine 20 (2008) 135–142
Where direct experimental research into a causal hypothesis of a disease is impossible due to ethical and practical considerations, epidemiological inference is the accepted route to establishing cause. Therefore, to examine the autism as mercury poisoning hypothesis, this paper reviews the existing scientific literature within the context of established epidemiological criteria and finds that the evidence for a causal relationship is compelling. Exposure to mercury (via vaccines and maternal dental amalgam) in utero and during infant years is confirmed; mercury poisoning is known to cause symptoms consistent with autism; animal modeling supports the link and, critically, mercury levels are higher in both the urine and blood of autistic children than in non-autistic peers. Analogous to epidemiological evidence of the smoking–lung cancer relationship, a mercury–autism relationship is confirmed.
...it would be negligent to continue to expose pregnant and nursing mothers and infant children to any amount of avoidable mercury.
The precautionary principle demands that health professionals not take an action if there is suspicion that the action may cause severe or lifelong health effects: it does not require certainty. Therefore, given the severity, devastating lifelong impact and extremely high prevalence of autism, it would be negligent to continue to expose pregnant and nursing mothers and infant children to any amount of avoidable mercury.
Click here for entire article.
Analysis by Dr. Mark Geier
The new in-depth analysis review article, "An Epidemiological Analysis of the 'Autism as Mercury Poisoning' Hypothesis" from the peer-reviewed International Journal of Risk & Safety in Medicine by Dr. David Austin, professor of Life and Social Science, Swinburne University of Technology, Melbourne, Australia, states, "Therefore, to examine the autism as mercury poisoning hypothesis, this paper reviews the existing scientific literature within the context of established epidemiological criteria and finds that the evidence for a causal relationship is compelling.
|...that researchers from multiple different universities, on 4 different continents...have now described a causal role for mercury, and in particular Thimerosal, and its relationship with autism and other neurodevelopmental disorders.
To put this new study in context, it means that researchers from multiple different universities, on 4 different continents (including: North America, South America, Europe, and Australia) have now described a causal role for mercury, and in particular Thimerosal, and its relationship with autism and other neurodevelopmental disorders.
USAAA Conference Highlights
Dr. Phillip C. DeMio (USAAA Chief Medical Officer), Dr. Lawrence P. Kaplan (USAAA Chairman and Founder), Holly Robinson Peete (Actress, Author, Singer, and USAAA 2008 Keynote Speaker), Gail B. Kaplan, Theresa K. Wrangham (USAAA Director of Education/Conference Liaison)
A complete recap of the conference will published in the next newsletter.
— Holly Robinson Peete kicks off conference with Keynote address.
— Dr. DeMio announces formation of American Medical Autism Board.
— Dr. Mark Geier and David Geier present for the first time, "New Clinical Study on Mercury Body-Burden, Severity, & Transsulfuration Biomarkers in Autism Spectrum Disorders", "New Human Neuronal & Fetal Tissue Culture Study Examines the Toxicity of Thimerosal", and The Genetic Centers of America Launches National Outreach Program for Patients with Autistic Disorders; Plan to Open New Autism Treatment Center in Texas.
— Dr. Valerie Paradiz, Dr. Stephen Shore and Marlo Payne Thurman present “Autism: Impact on Education," a full day workshop that was the first of its kind to be offered nationally within an autism conference format.
— Dr. Doris Rapp's first national autism presentation
— Sibling Panel Discussion
— Parent Practitioner Panel Discussion
— Concert pianist Michael Schneider's incredible performance at the USAAA dinner
Plus much more.
Click here to get all your conference DVDs including Holly Robinson Peete's Keynote Address
|GET YOUR DVDs from the
2008 USAAA International Conference
to get all your conference DVDs including Holly Robinson Peete's Keynote Address